Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,826-1,850 of 2,022
CompletedNCT00330551

Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia

This study exists to compare options and see whether a guided support group offers something meaningfully different. Researchers are trying to understand whether a guided support group can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
TerminatedNCT04404712

FAAH Availability in Psychiatric Disorders: A PET Study

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
CompletedNCT02535923

CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
CompletedNCT03921450

Overcoming Psychomotor Slowing in Psychosis (OCoPS-P)

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Switzerland
Sponsor
University of Bern
Condition
Schizophrenia
CompletedNCT04856657

Targeting Individual Alpha Frequencies to Enhance Perceptual Timing

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
CompletedNCT04010305

Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
BioXcel Therapeutics Inc
Condition
Schizophrenia
CompletedNCT03810755

EfiKroniK Research Program: Physical Exercise for People With Chronic Pathologies

This study exists to understand what helps smoking support or smoking-related treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
Spain
Sponsor
Basque Health Service
Condition
Schizophrenia
CompletedNCT04567524

A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules

This study exists to better understand the safety of a digital app or remote support tool and how manageable it feels in practice. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Lyndra Inc.
Condition
Schizophrenia
CompletedNCT05712928

eMove - Dance/Movement Therapy Study

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Drexel University
Condition
Schizophrenia
CompletedNCT04294719

A Study of Cognitive Adaptation Training in Inpatient Forensic Environments

This study exists to see whether the medication Cognitive is workable and worth testing more broadly. Researchers are trying to understand whether the medication Cognitive can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
CompletedNCT03769493

Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Butler Hospital
Condition
Schizophrenia
CompletedNCT03281629

Circuitry-Guided Smoking Cessation in Schizophrenia

This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
CompletedNCT04799717

Game-based Telehealth Therapeutic Intervention in First Onset Psychosis

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 10 Years to 18 Years
Countries
United States
Sponsor
Stanford University
Condition
Schizophrenia
CompletedNCT03869177

Implementation of Family Involvement for Persons With Psychotic Disorders.

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand what helps a digital app or remote support tool stay useful, realistic, and easier to follow over time.

SchizophreniaOtherOver 18 Years
Countries
Norway
Sponsor
University of Oslo
Condition
Schizophrenia
CompletedNCT03860597

Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
CompletedNCT02204787

Treatment of Negative Symptoms and Schizophrenia

This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Montpellier
Condition
Schizophrenia
CompletedNCT03893825

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

This study exists to understand how the medication TV-46000 holds up over time after the earliest research stage. Researchers are trying to understand whether the medication TV-46000 can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 13 Years to 65 Years
Countries
Bulgaria, Canada, France, Israel, United States
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Schizophrenia
CompletedNCT04709224

Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia

This study exists to learn from real-world information that can show how a medication treatment fits into care. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
CompletedNCT00982982

Effects of Delta-9-THC and Iomazenil in Healthy Humans

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia